MARY MORRISON: Open Payments
NPI 1386263010 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 17 payments from 6 companies in 2025. Trend: 2023 $240 · 2024 $96 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $179 |
| Ethicon US, LLC | 1 | $81 |
| Optinose US, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: NUCALA, LINX REFLUX MANAGEMENT SYSTEM, Xhance, DUPIXENT, TEZSPIRE.
Industry payments across CT — which companies pay providers there.
